New Enzyme Anhydrofructose-Reductase
The invention affects the novel bacterial enzyme 1,5-anhydro-D-fructose-reductase. In a regio- and stereoselective reaction 1,5-anhydro-D-fructose (AF) is quantitatively reduced to 1,5-anhydro-D-ma-nnitol. Generally AF occurs naturally in connection with the enzymatic degradation of storage poly-saccharides like starch or glycogen and the further eucaryotic metabolism results in the sugar polyol 1,5-anhydro-D-glucitol (so-called Third Gly-cogenolytic Pathway). The bacterial, NADPH-dependent enzyme exhibits a limited substrate spectrum and reduces other structure analogous 2-keto-aldoses. Due to the heterologous expression in E. coli the biocatalyst is available in sufficient amounts. The specific analysis of AF and selective synthesis of the manno-configurated reduction products are counted among the most important areas of application of the new AF-reductase.
Further Information: PDF
Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/9386376
Contact
Dipl.-Kfm. Axel Koch MBA, Dr. Dirk Schwingel
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Self-Destructing Cancer Cells: Cutting-Edge RNA Breakthrough
Jülich scientists use novel RNA technology to selectively switch off tumours in the brain. An Adaptable Platform Technology That Destroys Glioblastoma Cancer Cells Using a special RNA molecule, a team…
Endurance Training: Transforming Lives of Heart Failure Patients
Can strength and endurance training be beneficial for patients with a certain form of heart failure? A research team from Greifswald investigated this question together with seven other research centers…
A Wake-Up Call for Mediterranean Shark Protection Against Extinction
Overfishing, illegal fishing and increasing marketing of shark meat pose significant threats to the more than 80 species of sharks and rays that inhabit the Mediterranean Sea, according to a…